Combinations comprising dmxaa for the treatment of cancer

Details Combinations comprising dmxaa for the treatment of cancer Combinations comprising dmxaa for the treatment of cancer

A - Human Necessities

61

K

A61K 31/352 (2006.01) A61K 31/517 (2006.01) A61K 31/5377 (2006.01) A61K 39/395 (2006.01) A61P 35/00 (2006.01)

Patent

CA 2620447

The present invention relates to combinations of the xanthenone acetic acids class such as 5,6-dimethylxanthenone-4-acetic acid (DMXAA) and EGFR signalling pathway inhibitors. More particularly, the invention is concerned with the use of such combinations in the treatment of cancer and pharmaceutical compositions containing such combinations.

L'invention concerne des combinaisons de la catégorie des acides xanthénone-acétiques, tels qu'acide 5,6-diméthylxanthénone-4-acétique (DMXAA) et des inhibiteurs du trajet de signalisation de EGFR. Elle concerne, plus particulièrement, l'utilisation de ces combinaisons afin de traiter le cancer, ainsi que des compositions pharmaceutiques contenant ces combinaisons.

Affiliated with

Also associated with

Rating

Combinations comprising dmxaa for the treatment of cancer does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Combinations comprising dmxaa for the treatment of cancer, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Combinations comprising dmxaa for the treatment of cancer will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1597747